Erik Wist

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index6.9kcitations108works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(24), Cancer Treatment and Pharmacology(18), Cancer Genomics and Diagnostics(13), Childhood Cancer Survivors' Quality of Life(12), Cancer survivorship and care(11)

Publications107 total

Abstract P2-01-26: Carboplatin added to neoadjuvant chemotherapy in a randomized phase II study: Complex DNA based biomarkers predict response in hormone receptor positive and triple negative breast cancer
Clinical Cancer Research·2025
Data from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
2023Open Access
Figure S1, Figure S2 from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
2023Open Access
Data from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
2023Open Access
Supplementary Tables from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
2023Open Access
Figure S1, Figure S2 from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
2023Open Access
Supplementary Tables from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
2023Open Access
A complex communication skills training program for physicians providing advanced cancer care – content development and barriers and solutions for implementation
Journal of Communications In Healthcare·2022· 7 citedOpen Access
Abstract P3-14-08: The influence of metabolic factors, migration, and ethnic disparities on breast cancer risk and treatment
Cancer Research·2022
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of <scp>ER</scp>‐positive breast cancer
International Journal of Cancer·2020· 18 citedOpen Access
Abstract P1-13-01: Lipoprotein and metabolite responses to physical exercise during adjuvant breast cancer treatment
Cancer Research·2020
Vaksine mot influensere
Tidsskrift for Den norske legeforening·2019Open Access
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Genome Medicine·2018· 26 citedOpen Access
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
British Journal of Cancer·2018· 20 citedOpen Access
Additional file 4: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Figshare·2018Open Access
Additional file 2: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Figshare·2018Open Access
Additional file 3: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Figshare·2018Open Access
Additional file 5: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Figshare·2018Open Access
Additional file 7: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Figshare·2018Open Access
Additional file 6: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Figshare·2018Open Access
page 1 of 6Next →

Frequent Co-authors

Roy M. Bremnes(14), Sophie D. Fosså(14), Olbjørn Klepp(11), Alv A. Dahl(10), Olav Dahl(9), Jonas Bergh(5), Hans E. Krokan(5), Bjørn Naume(5), Per Malmström(4), Carl Blomqvist(4), Kristin V. Reinertsen(4), Jon Håvard Loge(4), Ingvil Mjaaland(4), Hans Prydz(4), Olav Engebraaten(4), Vessela N. Kristensen(4), Elin Borgen(4), Steinar Lundgren(4), Terje Risberg(4), Trine Bjøro(3)